NGL FINECHEM
Back to All Ratios
|
NGL FINECHEM Last 5 Year EV/CE History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/CE(x) | 2.11 | 4.46 | 2.98 | 4.47 | 4.62 |
What is the latest EV/CE ratio of NGL FINECHEM ?
Year | EV/CE |
---|---|
Mar2025 | 2.11 |
Mar2024 | 4.46 |
Mar2023 | 2.98 |
Mar2022 | 4.47 |
Mar2021 | 4.62 |
How is EV/CE of NGL FINECHEM Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2025 | 2.11 | -52.69 | |
Mar2024 | 4.46 | 49.66 | |
Mar2023 | 2.98 | -33.33 | |
Mar2022 | 4.47 | -3.25 | |
Mar2021 | 4.62 | - |
Other Financial Ratios of NGL FINECHEM
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹893.9 Cr | -3.1% | 7.7% | -34.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -3.1% |
7.7% |
-34.8% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses